Engimmune Therapeutics Announces the Appointment of Dr Annal

/PRNewswire/ -- Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to...

Related Keywords

Italy , United States , California , Switzerland , Swiss , American , Annalisa Dandrea , Kiniksa Pharmaceuticals , University Of Pennsylvania , Venture Partner At Longwood Fund , Bachelor Of Sciences , Novartis , Wistar Institute , University Of Siena , Research Institute In Palo Alto , University Of Florence , Venture Partner , Longwood Fund , Chief Scientific Officer , Vice President , Global Head , Executive Director , Section Head , Ddiscovery Biology , Chiron Vaccines , Palo Alto , Annalisad Andrea , Engimmune Therapeutics ,